Business
Mesoblast (ASX:MSB) share price jumps 19% on FDA update – Motley Fool Australia
The Mesoblast limited (ASX:MSB) share price is racing higher on Wednesday after the US FDA granted it a fast track designation for COVID-19 ARDS…
The Mesoblast limited(ASX: MSB) share price has started the day strongly and is racing materially higher.
At the time of writing, the biotechnology company’s shares are up 12% to $4.62. But at one stage they were up as much as 19% to $4.90.
Why is the Mesoblast share price racing higher?
Investors have been buying the company’s shares this morning after the release of a positive announcement relating to its remestemcel-L product.
According to the release, the United States Food and Drug Administration…
-
General10 hours agoNew Zealand wants more ‘automated decision-making’ in its welfare system. Could that lead to Robodebt 2.0?
-
General12 hours agoFrom Humpty Doo to the bush, these voters’ views reflect the challenge for federal politicians
-
Noosa News11 hours agoMajor emergency rescue following boat capsizing off Main Beach on the Gold Coast
-
Noosa News15 hours agoHorse missing in Victorian high country after Man from Snowy River re-enactment goes awry